| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |